At Penn Medicine's Abramson Cancer Center, patients with bile duct cancer receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gastrointestinal cancer.
Cholangiocarcinoma is a rare cancer involving the bile ducts. Bile ducts are the structures within the gastrointestinal tract that carry bile. Bile is the digestive fluid excreted by the liver, which flows via the bile ducts into the intestine.
There are two types of cholangiocarcinomas:
Cholangiocarcinomas can be further classified based on the tissue from which they arise. Most cholangiocarcinomas are adenocarcinomas, meaning they arise from glandular tissue.
Bile duct cancer is rare, accounting for about 3 percent of all gastrointestinal cancers.
Penn Medicine's multidisciplinary approach to cancer diagnosis and treatment provides better outcomes and gives patients access to the most advanced treatment, surgical techniques and clinical trials.
Because navigating a cancer diagnosis and treatment options can be difficult, patients who wish to connect with a cancer specialist at Penn Medicine can speak with a cancer nurse, who can help them make an appointment with the right physician.
To connect with a cancer nurse at Penn Medicine, patients should call 800-789-PENN (7366).